Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein receptor type IB (BMPR1B), also known as ALK6, is a transmembrane serine/threonine kinase that functions as a receptor for bone morphogenetic proteins (BMPs), which are part of the TGF-beta superfamily. BMPR1B plays critical roles in embryogenesis, endochondral bone formation, and cellular differentiation. Upon BMP ligand binding, BMPR1B forms a heteromeric complex with type II BMP receptors, initiating intracellular signaling primarily via SMAD proteins. Mutations or dysregulation of BMPR1B have been associated with pulmonary hypertension and skeletal malformations.
Kinase activation and SMAD phosphorylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone morphogenetic protein receptor type IB (BMPR1B).